You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 164 No. 8, April 26, 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (45)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in this journal
 Topic Collections
 •Dermatology
 •Dermatologic Disorders, Other
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Angioedema Associated With Angiotensin-Converting Enzyme Inhibitor Use

Outcome After Switching to a Different Treatment

Marco Cicardi, MD; Lorenza C. Zingale, MD; Luigi Bergamaschini, MD; Angelo Agostoni, MD

Arch Intern Med. 2004;164:910-913.

Background  Angiotensin-converting enzyme (ACE) inhibitors are associated with angioedema episodes that are potentially life-threatening. Few data are available on the outcome of patients reporting this adverse effect when they are switched to another drug. Scattered reports of angioedema associated with angiotensin II receptor blocker (ARB) use question the safety of using these drugs in patients with ACE inhibitor–related angioedema. We describe 64 consecutive patients with ACE inhibitor–related angioedema, the outcome after discontinuing this treatment, and the safety of using ARBs.

Methods  Retrospective analysis of 64 consecutive patients (January 1993 to June 2002) presenting with angioedema onset while receiving treatment with an ACE inhibitor.

Results  Patients were recommended to stop ACE inhibitor use, substituting it upon advice of the physician. Fifty-four patients were available for follow-up (median follow-up, 11 months; range, 1-80 months): 26 had switched to an ARB, 14 to a calcium antagonist, and 14 to other antihypertensive drugs. Angioedema disappeared or drastically reduced upon withdrawal of the ACE inhibitor in 46 patients (85%). For the remaining 8 patients, angioedema was due to a cause other than ACE inhibitor use in 2; angioedema persisted independent of the treatment and without apparent cause (idiopathic angioedema) in 4; angioedema persisted after switching to an ARB and disappeared upon its withdrawal in 2.

Conclusions  Stopping ACE inhibitor use without further assessments is a successful measure in the large majority of patients developing angioedema while taking this drug. Only a small percentage of patients with ACE inhibitor–related angioedema continue with this symptom when switched to an ARB.


From the Department of Internal Medicine, University of Milan, IRCCS Ospedale Maggiore, Milan, Italy. The authors have no relevant financial interest in this article.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Nickel and Sulfites Food Allergy in Patients With Angioedema Associated With ACE Inhibitor Use
Sergio De Marchi, Laura Perale, Emanuela Cecchin, and Leonardo Alberto Sechi
Arch Intern Med. 2005;165(7):814-815.
EXTRACT | FULL TEXT  

Nickel and Sulfites Food Allergy in Patients With Angioedema Associated With ACE Inhibitor Use—Reply
Marco Cicardi and Lorenza C. Zingale
Arch Intern Med. 2005;165(7):815.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation
Hunt et al.
J Am Coll Cardiol 2009;53:e1-e90.
FULL TEXT  

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation
2005 WRITING COMMITTEE MEMBERS et al.
Circulation 2009;119:e391-e479.
FULL TEXT  

Angioedema After Local Trauma in a Patient on Angiotensin-Converting Enzyme Inhibitor Therapy
Simmons et al.
J Am Board Fam Med 2008;21:577-579.
ABSTRACT | FULL TEXT  

Olmesartan Medoxomil-Induced Angioedema
Nykamp and Winter
The Annals of Pharmacotherapy 2007;41:518-520.
ABSTRACT | FULL TEXT  

Angioedema without urticaria: a large clinical survey.
Zingale et al.
CMAJ 2006;175:1065-1070.
ABSTRACT | FULL TEXT  

Genetic Test Indications and Interpretations in Patients With Hereditary Angioedema
Weiler and Van Dellen
Mayo Clin Proc. 2006;81:958-972.
ABSTRACT | FULL TEXT  

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)
Developed in Collaboration With the American Colle et al.
J Am Coll Cardiol 2005;46:1116-1143.
FULL TEXT  

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society
Hunt et al.
Circulation 2005;112:1825-1852.
FULL TEXT  

Nickel and Sulfites Food Allergy in Patients With Angioedema Associated With ACE Inhibitor Use--Reply
Cicardi and Zingale
Arch Intern Med 2005;165:815-815.
FULL TEXT  

Nickel and Sulfites Food Allergy in Patients With Angioedema Associated With ACE Inhibitor Use
De Marchi et al.
Arch Intern Med 2005;165:814-815.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.